FAITH CHARLES

Profile

First Name

: FAITH

Middle Name

:

Last Name

: CHARLES

Related Companies

Titles

Company Name

Related People

DIRECTOR

BRIAN BIRK, DEE BRESCIA, BILL ENLOE, EBETUEL PALLARES, JOSEPH PATTI, FEDERICA PERICLE, DEBORA E RAMIREZ, STUART ROSE, WANETA TUTTLE, WANETA C TUTTLE, BRAD VALE

DIRECTOR

SANDSTONE DIAGNOSTICS INC

RICHARD BRENNER, KAREN DREXLER, ROBERT EASTON, JUNE FALLON, JUNE FALLON PAYNE, KEVIN KING, PAUL MANNERS, EBETUEL PALLARES, SARA NAAB SCHAFF, ULRICH SCHAFF, GREGORY SOMMER

DIRECTOR

CHRISTINE AYLWARD, JAMES KHODABAKHSH, STELLA SARRAF, JERRE L. STEAD, JACK THRIFT, CPA, MERVYN TURNER

DIRECTOR

AVENUE THERAPEUTICS, INC.

NEIL HERSKOWITZ, DAVID J. HORIN, DAVID JIN, JAY KRANZLER, M.D., PH.D., LUCY LU, M.D., ALEXANDRA MACLEAN, M.D., CURTIS OLTMANS, JEFFREY PALEY, M.D., SCOTT A. RAINES, M.D., SCOTT A. REINES, M.D., PH.D., LINDSAY A. ROSENWALD, M.D., MICHAEL RYAN, M.S., AKHTAR SAMAD, M.D. PH.D., MICHAEL WEISS

DIRECTOR

CNS PHARMACEUTICALS, INC.

BETTINA COCKROFT, MICHAL FISHER, JEFFRY KEYES, RAMI LEVIN, AMY MAHERY, STEVE O-LOUGHLIN

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2026-05-04

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

2023-01-27

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-02-16

D

BIOTECHNOLOGY

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]

$1 - $1,000,000

Equity

2019-12-11

D

OTHER TECHNOLOGY

DECLINE TO DISCLOSE

Equity

2019-11-18

D/A

BIOTECHNOLOGY

$1 - $1,000,000

Equity

2018-04-27

D

OTHER TECHNOLOGY

DECLINE TO DISCLOSE

Equity, Debt

2019-04-29

D

BIOTECHNOLOGY

$1 - $1,000,000

Equity

2018-04-27